|
WO2020201319A1
|
|
3d printing compositions for modified-release pharmaceutical applications
|
|
EP3771885A1
|
|
Refractive profilometry
|
|
EP3768048A1
|
|
Dielectric barrier discharge plasma reactor and method for plasma-enhanced vapor deposition
|
|
AU2019299495A1
|
|
Method for evaluating a risk of neurodevelopmental disorder with a child
|
|
KR20210005597A
|
|
WNT signaling agonist molecule
|
|
EP3685779A1
|
|
Device for cold plasma treatment, cold plasma endoscopic system, and method for generating and transporting a cold plasma
|
|
EP3673895A1
|
|
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
WO2020135920A1
|
|
Kit for inhaled chemotherapy, and treatment of lung cancer with said kit
|
|
EP3669934A1
|
|
Tissue anchoring assembly
|
|
WO2020048607A1
|
|
Srsf2 as rna epigenetic factor
|
|
WO2019012105A1
|
|
Method for predicting responsiveness to immunotherapy
|
|
EP3591665A1
|
|
Method for evaluating a risk of neurodevelopmental disorder with a child
|
|
CN110869114A
|
|
Droplet and/or bubble generator
|
|
EP3570008A1
|
|
Nitrogen trichloride analyser
|
|
EP3566760A1
|
|
Method for nucleating crystals from a solution in a capillary tube
|
|
CA3058290A1
|
|
Biomarkers and targets for proliferative diseases
|
|
CA3054915A1
|
|
Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker
|
|
EP3589221A1
|
|
Device for shearing tissue
|
|
EP3571510A1
|
|
Immunoassay methods and devices
|
|
EP3510925A1
|
|
Endoscopic non-contact measurement device
|
